TAM was also found to promote CSC phenotype and tumorigenesis in breast cancer by activating the EGFR/Stat3/Sox-2 signaling pathway, while inhibition of Sox2 mitigates TAM mediated induction of CSC phenotype and breast tumor growth [63]. The gene discussed is STAT3; the disease is breast carcinoma.